CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 55 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $33,000 | -81.5% | 10,536 | -0.4% | 0.00% | -85.2% |
| Q2 2018 | $178,000 | -89.2% | 10,574 | -83.5% | 0.03% | -90.8% |
| Q4 2017 | $1,655,000 | +357.2% | 63,974 | +201.5% | 0.29% | +245.9% |
| Q1 2017 | $362,000 | +112.9% | 21,217 | +70.2% | 0.08% | +84.8% |
| Q1 2016 | $170,000 | -19.8% | 12,466 | +10.2% | 0.05% | -36.1% |
| Q3 2015 | $212,000 | – | 11,312 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |